Is demand for aesthetic treatments changing, and should it change the way you plan for 2027?
The International Society of Aesthetic Plastic Surgery (ISAPS) published its latest global survey on 29 September 2026, covering procedures performed in 2025.
Itโs one of the most widely quoted data sets in our sector, and this yearโs results contain some notable shifts.
As a UK supplier working with aesthetics practitioners every day, weโve read the report closely so you donโt have to.
In this article, we summarise the headline findings, explain what the data can and canโt tell us about the UK, and suggest some practical steps for your clinic.
What Is The ISAPS Global Survey?
The ISAPS International Survey on Aesthetic/Cosmetic Procedures is an annual survey of plastic surgeons around the world.
For the 2025 data, 2,900 plastic surgeons responded, and ISAPS projected the results to an estimated 60,400 plastic surgeons worldwide (ISAPS 2025, p4).
This year, 51 locations are reported individually, up from 32 last year. ISAPS notes that this change affects the worldwide totals (p4).
One point matters more than any other when reading the figures. The survey counts procedures performed by plastic surgeons only.
In the UK, most non-surgical treatments are carried out by nurses, doctors, dentists and pharmacists, who arenโt surveyed.
So the report is a useful indicator of direction, but it isnโt a measure of the whole UK non-surgical market.
What Do The Worldwide Figures Show?
Across all locations, plastic surgeons reported 17,320,420 non-surgical procedures in 2025, down 15.7% on 2024 (ISAPS 2025, p10; plastic surgeons only).
Most individual categories fell. Among the changes ISAPS reports for 2025 against 2024 (p10, plastic surgeons only):
Hyaluronic acid filler: down 25.2%
Botulinum toxin: down 7.0%
Chemical peels: down 19.5%
Poly-L-lactic acid (PLLA): down 33.7%
Non-surgical fat reduction: down 42.2%
Non-surgical skin tightening: up 23.3%
ISAPS notes that these percentage changes compare only procedures that appeared in both yearsโ surveys (p10).
Surgery was broadly flat, at -0.4%, but some lift procedures grew strongly. Breast lift rose 48.1% and brow lift 23.5% (pp9, 13).
The report doesnโt say why these shifts happened, so weโd be cautious about reading too much into any single cause.
Is Dermal Filler Demand Really Falling?
Among plastic surgeons, the numbers point that way.
Worldwide, hyaluronic acid filler procedures fell from 6,338,184 to 4,737,957, a drop of 25.2% (ISAPS 2025, p10; plastic surgeons only).
The trend is similar closer to home. By our own calculation, UK plastic surgeonsโ hyaluronic acid procedures fell 22.7%, from 6,415 to 4,957 (ISAPS 2024, p35; ISAPS 2025, p46).
Those UK figures come from a small surgeon sample, so treat them as indicative rather than precise.
Filler remains the second most common non-surgical procedure among UK plastic surgeons, at 32.5% of their non-surgical work (p46).
The report doesnโt say why filler fell. One possible explanation is a move towards subtler, more considered treatment plans, but thatโs our interpretation rather than something the data shows.
Why Is Skin Tightening The Only Category Growing?
Non-surgical skin tightening was the only non-surgical category to grow worldwide in 2025.
It rose 23.3%, to 1,528,552 procedures, and is up 52.3% on 2021 (ISAPS 2025, p10; plastic surgeons only).
That headline needs some context, though.
In the US, the growth was far smaller. By our own calculation, US plastic surgeonsโ skin tightening procedures rose only about 1.2%, from 356,072 to 360,329 (ISAPS 2024, p15; ISAPS 2025, p16; plastic surgeons only).
US skin tightening held its volume while total US non-surgical procedures fell, so its share rose from 8.5% to 11.1%.
In other words, the worldwide growth isnโt being driven equally everywhere, and it may partly reflect the larger number of locations in this yearโs survey.
What About Biostimulators Like PLLA?
This is where the data is most mixed.
Worldwide, PLLA procedures fell 33.7%, from 642,566 to 426,019 (ISAPS 2025, p10; plastic surgeons only).
That follows a very large rise in the previous survey, so 2025 may be a pull-back after a strong run rather than a long-term decline. Again, thatโs our reading.
In the US, PLLA moved the other way. By our own calculation, US plastic surgeonsโ PLLA procedures rose about 35%, from 62,694 to 84,464 (ISAPS 2024, p15; ISAPS 2025, p16; plastic surgeons only).
Year-on-year US changes compare two separate survey samples, so the direction is more reliable than the exact size.
For UK practitioners, the honest summary is that biostimulators are neither booming nor fading in this data. The picture varies by country.
Where Does The UK Sit?
The UK has its own page in the report (p46).
UK plastic surgeons reported 134,063 procedures in 2025, of which 15,236 were non-surgical (plastic surgeons only).
That non-surgical figure is a small slice of UK activity, because most UK non-surgical treatments are outside the survey.
By our own calculation, comparing the UK pages of the last two surveys (ISAPS 2024, p35; ISAPS 2025, p46; plastic surgeons only):
Total non-surgical procedures fell 32.4%, from 22,526 to 15,236
Botulinum toxin procedures fell 21.1%, from 11,081 to 8,748
Hyaluronic acid procedures fell 22.7%, from 6,415 to 4,957
ISAPS doesnโt publish UK year-on-year changes itself, and the UK sample is small, so these are indicative only.
Two further points stand out in our analysis.
The UKโs treatment mix closely resembles Germanyโs.
Botulinum toxin and hyaluronic acid make up 57.4% and 32.5% of UK surgeonsโ non-surgical procedures, against 57.0% and 32.5% in Germany (ISAPS 2025, pp21, 46; plastic surgeons only).
The UKโs direction of travel looks closer to the US.
By our calculation, botulinum toxin and hyaluronic acid procedures both fell by roughly a fifth among UK and US plastic surgeons between the two surveys (ISAPS 2024, pp15, 35; ISAPS 2025, pp16, 46).
The report also leaves gaps. The surveyโs non-surgical categories (ISAPS 2025, p12) donโt list skin boosters, polynucleotides, threads or mesotherapy separately, so it canโt tell us how those treatments are performing.
What Does This Mean For Your Clinic?
No single survey should drive big business decisions. But the data does suggest some sensible steps.
Read headlines with care
When you see ISAPS figures quoted, check whether they are worldwide or country-level, and remember they cover plastic surgeons only.
Look at your own numbers first
Your appointment and treatment records are the best guide to demand in your clinic. Compare 2025 and 2026 by treatment type to see whether youโre following the wider pattern.
Review your consultation approach
With filler volumes falling among surgeons, it may be worth revisiting how you discuss natural-looking results, treatment planning and realistic expectations with patients.
Think about treatment pathways, not single treatments
Where itโs clinically appropriate, consider how different procedures fit together over a course of care, rather than relying on one-off appointments.
Keep your skills and evidence base current
Categories rise and fall. Ongoing training, good clinical records and a clear understanding of the evidence will serve you well whichever way the market moves.
Looking Ahead: What Happens Next?
The 2025 ISAPS data points to a more cautious, more selective aesthetics market, at least among plastic surgeons.
Filler and most other non-surgical categories fell, skin tightening grew worldwide but barely moved in the US, and biostimulators showed a mixed picture.
For the UK, the surgeon data is limited, but it suggests UK plastic surgeonsโ figures are moving in a similar direction to the US.
At Teleta, weโll keep following the data and sharing what it means for UK practitioners as new figures are published.
If you have questions about this article, or thereโs a market trend youโd like us to look into, please feel free to contact our team at support@teleta.co.uk or on Whatsapp.
Statistical data in this article is credited to the International Society of Aesthetic Plastic Surgery (ISAPS). Figures labelled as our own calculation are Teletaโs arithmetic on published ISAPS figures and are not ISAPS statistics. This article is provided for general information for healthcare professionals and does not constitute clinical, legal or business advice.
OK, sometimes we don’t want to type in the website address… EVERY TIME… we want to visit that site. Sometimes we would just like to click a button! So, add Teleta to your mobile phones home screen! It’s pretty straight forward: iPad or iPhone Launch โSafariโ app. ย This does not work from the โChromeโ app …
Last week was โeventfulโ to say the least! Clear government guidance, although trying to keep us all safe, has been pretty irregular and susceptible to interpretation or quick changes of direction. That said, it is much clearer now and we can’t wait to see your social media light up again with all the treatments and …
Operating times through Festive Period 2020 Due to Government restrictions, as of Tuesday 22nd of December, deliveries to businesses currently residing within a T4 restricted area will be delivered on 29th of December Monday 21st December – OPEN Tuesday 22nd December – OPEN Wednesday 23rd December – OPEN (9am-1pm) Orders from this date will be …
Operating times and delivery schedules through Easter Period 2022 Due to the Bank Holiday on Monday, 18th April 2022, we have a change to our delivery schedule: Thursday 14th April – OPEN (Refrigerated orders from this date will be delivered Wednesday, 20th April) Thursday 14th April – OPEN (Non Refrigerated orders, unless Saturday delivery specified …
Market Insights: what the latest global aesthetics data could mean for UK practice.
Is demand for aesthetic treatments changing, and should it change the way you plan for 2027?
The International Society of Aesthetic Plastic Surgery (ISAPS) published its latest global survey on 29 September 2026, covering procedures performed in 2025.
Itโs one of the most widely quoted data sets in our sector, and this yearโs results contain some notable shifts.
As a UK supplier working with aesthetics practitioners every day, weโve read the report closely so you donโt have to.
In this article, we summarise the headline findings, explain what the data can and canโt tell us about the UK, and suggest some practical steps for your clinic.
What Is The ISAPS Global Survey?
The ISAPS International Survey on Aesthetic/Cosmetic Procedures is an annual survey of plastic surgeons around the world.
For the 2025 data, 2,900 plastic surgeons responded, and ISAPS projected the results to an estimated 60,400 plastic surgeons worldwide (ISAPS 2025, p4).
This year, 51 locations are reported individually, up from 32 last year. ISAPS notes that this change affects the worldwide totals (p4).
One point matters more than any other when reading the figures. The survey counts procedures performed by plastic surgeons only.
In the UK, most non-surgical treatments are carried out by nurses, doctors, dentists and pharmacists, who arenโt surveyed.
So the report is a useful indicator of direction, but it isnโt a measure of the whole UK non-surgical market.
What Do The Worldwide Figures Show?
Across all locations, plastic surgeons reported 17,320,420 non-surgical procedures in 2025, down 15.7% on 2024 (ISAPS 2025, p10; plastic surgeons only).
Most individual categories fell. Among the changes ISAPS reports for 2025 against 2024 (p10, plastic surgeons only):
ISAPS notes that these percentage changes compare only procedures that appeared in both yearsโ surveys (p10).
Surgery was broadly flat, at -0.4%, but some lift procedures grew strongly. Breast lift rose 48.1% and brow lift 23.5% (pp9, 13).
The report doesnโt say why these shifts happened, so weโd be cautious about reading too much into any single cause.
Is Dermal Filler Demand Really Falling?
Among plastic surgeons, the numbers point that way.
Worldwide, hyaluronic acid filler procedures fell from 6,338,184 to 4,737,957, a drop of 25.2% (ISAPS 2025, p10; plastic surgeons only).
The trend is similar closer to home. By our own calculation, UK plastic surgeonsโ hyaluronic acid procedures fell 22.7%, from 6,415 to 4,957 (ISAPS 2024, p35; ISAPS 2025, p46).
Those UK figures come from a small surgeon sample, so treat them as indicative rather than precise.
Filler remains the second most common non-surgical procedure among UK plastic surgeons, at 32.5% of their non-surgical work (p46).
The report doesnโt say why filler fell. One possible explanation is a move towards subtler, more considered treatment plans, but thatโs our interpretation rather than something the data shows.
Why Is Skin Tightening The Only Category Growing?
Non-surgical skin tightening was the only non-surgical category to grow worldwide in 2025.
It rose 23.3%, to 1,528,552 procedures, and is up 52.3% on 2021 (ISAPS 2025, p10; plastic surgeons only).
That headline needs some context, though.
In the US, the growth was far smaller. By our own calculation, US plastic surgeonsโ skin tightening procedures rose only about 1.2%, from 356,072 to 360,329 (ISAPS 2024, p15; ISAPS 2025, p16; plastic surgeons only).
US skin tightening held its volume while total US non-surgical procedures fell, so its share rose from 8.5% to 11.1%.
In other words, the worldwide growth isnโt being driven equally everywhere, and it may partly reflect the larger number of locations in this yearโs survey.
What About Biostimulators Like PLLA?
This is where the data is most mixed.
Worldwide, PLLA procedures fell 33.7%, from 642,566 to 426,019 (ISAPS 2025, p10; plastic surgeons only).
That follows a very large rise in the previous survey, so 2025 may be a pull-back after a strong run rather than a long-term decline. Again, thatโs our reading.
In the US, PLLA moved the other way. By our own calculation, US plastic surgeonsโ PLLA procedures rose about 35%, from 62,694 to 84,464 (ISAPS 2024, p15; ISAPS 2025, p16; plastic surgeons only).
Year-on-year US changes compare two separate survey samples, so the direction is more reliable than the exact size.
For UK practitioners, the honest summary is that biostimulators are neither booming nor fading in this data. The picture varies by country.
Where Does The UK Sit?
The UK has its own page in the report (p46).
UK plastic surgeons reported 134,063 procedures in 2025, of which 15,236 were non-surgical (plastic surgeons only).
That non-surgical figure is a small slice of UK activity, because most UK non-surgical treatments are outside the survey.
By our own calculation, comparing the UK pages of the last two surveys (ISAPS 2024, p35; ISAPS 2025, p46; plastic surgeons only):
ISAPS doesnโt publish UK year-on-year changes itself, and the UK sample is small, so these are indicative only.
Two further points stand out in our analysis.
The UKโs treatment mix closely resembles Germanyโs.
Botulinum toxin and hyaluronic acid make up 57.4% and 32.5% of UK surgeonsโ non-surgical procedures, against 57.0% and 32.5% in Germany (ISAPS 2025, pp21, 46; plastic surgeons only).
The UKโs direction of travel looks closer to the US.
By our calculation, botulinum toxin and hyaluronic acid procedures both fell by roughly a fifth among UK and US plastic surgeons between the two surveys (ISAPS 2024, pp15, 35; ISAPS 2025, pp16, 46).
The report also leaves gaps. The surveyโs non-surgical categories (ISAPS 2025, p12) donโt list skin boosters, polynucleotides, threads or mesotherapy separately, so it canโt tell us how those treatments are performing.
What Does This Mean For Your Clinic?
No single survey should drive big business decisions. But the data does suggest some sensible steps.
When you see ISAPS figures quoted, check whether they are worldwide or country-level, and remember they cover plastic surgeons only.
Your appointment and treatment records are the best guide to demand in your clinic. Compare 2025 and 2026 by treatment type to see whether youโre following the wider pattern.
With filler volumes falling among surgeons, it may be worth revisiting how you discuss natural-looking results, treatment planning and realistic expectations with patients.
Where itโs clinically appropriate, consider how different procedures fit together over a course of care, rather than relying on one-off appointments.
Categories rise and fall. Ongoing training, good clinical records and a clear understanding of the evidence will serve you well whichever way the market moves.
Looking Ahead: What Happens Next?
The 2025 ISAPS data points to a more cautious, more selective aesthetics market, at least among plastic surgeons.
Filler and most other non-surgical categories fell, skin tightening grew worldwide but barely moved in the US, and biostimulators showed a mixed picture.
For the UK, the surgeon data is limited, but it suggests UK plastic surgeonsโ figures are moving in a similar direction to the US.
At Teleta, weโll keep following the data and sharing what it means for UK practitioners as new figures are published.
If you have questions about this article, or thereโs a market trend youโd like us to look into, please feel free to contact our team at support@teleta.co.uk or on Whatsapp.
Statistical data in this article is credited to the International Society of Aesthetic Plastic Surgery (ISAPS). Figures labelled as our own calculation are Teletaโs arithmetic on published ISAPS figures and are not ISAPS statistics. This article is provided for general information for healthcare professionals and does not constitute clinical, legal or business advice.
Sources
Related Posts
Save typing, add teleta.co.uk to your mobile home screen
OK, sometimes we don’t want to type in the website address… EVERY TIME… we want to visit that site. Sometimes we would just like to click a button! So, add Teleta to your mobile phones home screen! It’s pretty straight forward: iPad or iPhone Launch โSafariโ app. ย This does not work from the โChromeโ app …
‘Kissability’ Study Released & Guidance On Facial Treatments
Last week was โeventfulโ to say the least! Clear government guidance, although trying to keep us all safe, has been pretty irregular and susceptible to interpretation or quick changes of direction. That said, it is much clearer now and we can’t wait to see your social media light up again with all the treatments and …
Festive Season 2020 Operating times 21st Dec – 5th Jan
Operating times through Festive Period 2020 Due to Government restrictions, as of Tuesday 22nd of December, deliveries to businesses currently residing within a T4 restricted area will be delivered on 29th of December Monday 21st December – OPEN Tuesday 22nd December – OPEN Wednesday 23rd December – OPEN (9am-1pm) Orders from this date will be …
Operating times and delivery schedules through Easter Period 2022
Operating times and delivery schedules through Easter Period 2022 Due to the Bank Holiday on Monday, 18th April 2022, we have a change to our delivery schedule: Thursday 14th April – OPEN (Refrigerated orders from this date will be delivered Wednesday, 20th April) Thursday 14th April – OPEN (Non Refrigerated orders, unless Saturday delivery specified …